Insulin-Like Growth Factor I Deficiency
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
1
|
2
|
0.800 |
strong |
1.000 |
3 |
2
|
1993 |
2020 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
1
|
0.600 |
None |
1.000 |
3 |
|
2002 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1074
|
1390
|
0.600 |
None |
0.955 |
2 |
|
1986 |
2020 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
190
|
233
|
0.600 |
None |
0.931 |
2 |
|
1993 |
2020 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
176
|
|
0.550 |
None |
1.000 |
1 |
|
2003 |
2011 |
Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
110
|
4
|
0.510 |
None |
1.000 |
1 |
|
2003 |
2008 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
774
|
|
0.500 |
None |
1.000 |
2 |
|
2003 |
2010 |
Metabolic Bone Disorder
|
group |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
14
|
|
0.500 |
None |
1.000 |
1 |
|
2000 |
2011 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.500 |
None |
1.000 |
1 |
|
2009 |
2014 |
Diaphragmatic Hernia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
41
|
|
0.500 |
None |
1.000 |
1 |
|
1999 |
2001 |
Osteopenia
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
15
|
23
|
0.480 |
None |
1.000 |
1 |
|
2000 |
2019 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
289
|
7
|
0.400 |
None |
1.000 |
5 |
|
1996 |
2018 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
254
|
|
0.400 |
None |
1.000 |
5 |
|
1996 |
2018 |
Acromegaly
|
disease |
Musculoskeletal Diseases; Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
5
|
|
0.400 |
None |
0.977 |
4 |
|
1991 |
2020 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
616
|
281
|
0.400 |
None |
0.946 |
3 |
|
1993 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
538
|
763
|
0.400 |
None |
0.959 |
2 |
|
1986 |
2020 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
316
|
0.400 |
None |
1.000 |
2 |
|
1990 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
507
|
203
|
0.400 |
None |
0.962 |
1 |
|
1989 |
2019 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
45
|
611
|
0.400 |
None |
0.955 |
1 |
|
1994 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
217
|
|
0.400 |
None |
1.000 |
1 |
|
1997 |
2019 |
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
140
|
3
|
0.400 |
None |
0.846 |
1 |
|
1996 |
2019 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
36
|
|
0.400 |
None |
0.875 |
1 |
|
1992 |
2019 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
101
|
952
|
0.400 |
None |
1.000 |
1 |
|
2000 |
2020 |
Malignant neoplasm of urinary bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
141
|
41
|
0.400 |
None |
0.833 |
1 |
|
2001 |
2019 |
Cachexia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
12
|
2
|
0.380 |
None |
1.000 |
1 |
|
2002 |
2019 |